Search results

  1. chillier

    Genetics: Chromosome 20: ARFGEF2, CSE1L, STAU1

    From the candidate gene list it seems the locus on chromosome 20 is associated with many other interesting looking genes. For instance ZNFX1, where the eQTL data suggests expression of this gene is increased in brain and pancreas. There was an EMBO paper I saw that argues that ZNFX1 inhibits...
  2. chillier

    Genetics: RABGAP1L

    RABGAP1L is involved in vesicle trafficking near the cell membrane and is highly expressed in neurons - both also true of ATP9A and USP6NL from precisionLIfe's me/cfs and long covid studies - all three heavily associated with Rabs. I wonder if an alternative possible function to pathogen entry...
  3. chillier

    Genetics: FBXL4

    CLOCK was one of the genes found in precisionLife's ME/CFS genetics study in the UK biobank, and replicated later in a long covid cohort
  4. chillier

    Preprint Initial findings from the DecodeME genome-wide association study of myalgic encephalomyelitis/chronic fatigue syndrome, 2025, DecodeMe Collaboration

    Thank you so much @Chris Ponting @Andy and the decode team. There's no words really to properly express the gratitude. Loss of function causes excess culling of mitochondria leading to mitochondrial DNA depletion syndrome or mitochondrial encephalopathy. This reminded me of something from Josh...
  5. chillier

    Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum, 2026, Ryback et al

    The seahorse assay introduces a lot of technical variation in general, but there will be even more in our particular set up because the cells (which are seeded in their wells near confluence) have been incubating in serum for a whole week prior to running the actual assay. We are not looking at...
  6. chillier

    How should biological researchers present their results about ME/CFS to the media - discussion thread.

    'in your head' is an idiom meaning 'isn't real / based on worry and overthinking'. It's dismissive to say that about any disease whether psychiatric or of the body. Personally I think it's even a little flippant to say to someone who really is just a bit worried about something.
  7. chillier

    Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity, 2024, Beentjes, Ponting et al

    If you do a statistical test with a significance threshold of p = 0.05, by definition there is a 5% of you getting a positive result by chance. Therefore if you do ~3000 tests as the authors have done in this paper, you expect to see 5% of those tests to be positive completely spuriously = 150...
  8. chillier

    Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity, 2024, Beentjes, Ponting et al

    Very poor response from Alan Carson, he appears to either not understand what multiple testing correction is, or just assume without reading the paper that the authors haven't done it.
  9. chillier

    Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum, 2026, Ryback et al

    @Jonathan Edwards I want to push back on that point about the critic at UCL. I wasn't at the UCL meeting of course but I don't get the impression this person was acting in good faith. The tone was aggressive to the point that people came up to Audrey after her talk to apologise for his...
  10. chillier

    Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum, 2026, Ryback et al

    Yep, so to be clear we did have severe pwME in the study, just relatively few. I believe something like 5 severe out of 67 total. If you just look at the severe people only there is still no difference between them and the healthy controls. To get more would have required at home sampling which...
  11. chillier

    Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum, 2026, Ryback et al

    The points raised about PEM and severity are the biggest limitations I completely agree. All the participants had to have been well enough to physically attend the university, but this doesn't mean they weren't very sick. The complete lack of any even incremental trend towards increased OCR in...
  12. chillier

    Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum, 2026, Ryback et al

    We would have liked to a see a positive result obviously but what we really wanted was to get a clear answer about whether the 'factor in blood' work done previously was real. It's been an unresolved question for quite a while now and we thought we and the community deserved to know. We put a...
  13. chillier

    Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum, 2026, Ryback et al

    See post #76 for peer-reviewed version. Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum Audrey A. Ryback, Charles Hillier, Camila M Loureiro, Chris P Ponting, Caroline F Dalton Myalgic Encephalomyelitis (ME)/Chronic...
  14. chillier

    Webinar 2pm today (Friday 6 June 2025): Genetics Centre of Excellence (Edinburgh Ponting lab): update on recent research

    haha :D one of my ME symptoms is terrible thermoregulation so both are true!
  15. chillier

    Webinar 2pm today (Friday 6 June 2025): Genetics Centre of Excellence (Edinburgh Ponting lab): update on recent research

    Thanks Simon :) We submitted the preprint to biorxiv earlier in the week so hopefully it'll be out soon. Maybe monday? EDIT: As if on cue! It came out at the same time I made this comment.
  16. chillier

    National patterns of age of ME/CFS onset

    Yep, mean age at time of filling out is very similar but that doesn't mean the underlying distribution has to look the same so we can check. Since we have the age of onset and the age at the time of filling out the form it means we could also check how the age at onset has changed over the...
  17. chillier

    Could nerve damage or retrograde microtubule based transport in axons explain the delay associated with PEM?

    Perhaps more likely to be temporary, though if there was more permanent damage to types of sensory neurons that don't directly lead to an obvious loss of touch sensation would that really be detectable with neurophysiology techniques? I don't know the extent of what's possible with these...
  18. chillier

    Could nerve damage or retrograde microtubule based transport in axons explain the delay associated with PEM?

    Fair enough but I'm not suggesting there's retrograde degeneration, but a delay between an event such as damage at the neuron terminals and a phenotype occuring possibly mediated by this retrograde movement. You might be right about sensitisation at the DRG but does it necessarily need to happen...
  19. chillier

    Could nerve damage or retrograde microtubule based transport in axons explain the delay associated with PEM?

    Yes exactly that's the thinking here. I can't give good answers to these fair questions I'm afraid I can only speculate. I don't know of course whether the smaller PEM events like over a few days and the disastrous huge relapses type PEM are just degrees of the same phenomenon or not. For me...
  20. chillier

    Could nerve damage or retrograde microtubule based transport in axons explain the delay associated with PEM?

    There appears to be a process called Wallerian(-like) degeneration of nerves which also follows a similar time delay pattern. After nerve damage (eg crush), the neurons can retain electrical activity for (according to wikipedia) 24-36 before the axon degenerates and macrophages infiltrate the...
Back
Top